Aura Biosciences (AURA) Other Non-Current Liabilities (2020 - 2022)
Aura Biosciences' (AURA) quarterly Other Non-Current Liabilities came in at $67000.0 in Q2 2022, down 47.24% on a QoQ basis from $127000.0 in Q1 2022.
Aura Biosciences (AURA) Other Non-Current Liabilities (2020 - 2022) Analysis & Trends
Aura Biosciences (AURA) has 3 years of Other Non-Current Liabilities data on file, last reported at $67000.0 in Q2 2022.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $67000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $67000.0 (changed N/A YoY) and the FY2021 annual result came in at $83000.0, up 15.28% from the prior year.
- Other Non-Current Liabilities declined to $67000.0 in Q2 2022, from $127000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $127000.0 in Q1 2022 to a low of $67000.0 in Q2 2022.
- A 3-year average of $84000.0 and a median of $72000.0 in 2020 frame the typical range for Other Non-Current Liabilities.
- The widest YoY moves for Other Non-Current Liabilities: up 15.28% in 2021, down 15.28% in 2021.
- Tracing AURA's Other Non-Current Liabilities over 3 years: stood at $72000.0 in 2020, then grew by 15.28% to $83000.0 in 2021, then decreased by 19.28% to $67000.0 in 2022.
- The last three Other Non-Current Liabilities figures came in at $67000.0 (Q2 2022), $127000.0 (Q1 2022), and $83000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Aura Biosciences | 797.49 Mn | 729.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 67,000.00 |
| Mar 31, 2022 | 127,000.00 |
| Dec 31, 2021 | 83,000.00 |
| Sep 30, 2021 | 71,000.00 |
| Dec 31, 2020 | 72,000.00 |